REPORT ID 6237

United States Competent Cells Market Report 2019

Publish Date
2019
Pages
116
Format
Electronic (PDF)

In this report, the United States Competent Cells market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Competent Cells in these regions, from   2019 to 2025 (forecast).

United States Competent Cells market competition by top manufacturers/players, with Competent Cells sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Merck KGaA (Germany)
    Promega Corporation (U.S.)
    Thermo Fisher Scientific, Inc. (U.S)
    New England Biolabs (U.S.)
    Takara Bio (Japan)
    Agilent Technologies (U.S.)
    Lucigen (U.S.)
    QIAGEN N.V. (Germany)
    OriGene Technologies (U.S.)
    Bioline (U.K.)
    Zymo Research (U.S.)
    Beijing TransGen Biotech Co., Ltd. (China)
    Source BioScience (U.K.)
    IBA GmBH (Germany)
    Genewiz (U.S.)
    BioDynamics Laboratory, Inc. (Japan)
    GCC Biotech (India)
    SMOBIO Technology (Taiwan)
    GeneScript Corporation (U.S.)
    Bio-Rad Laboratories (U.S.)
    Life Technologies (India) Pvt. Ltd.
    Cell Applications, Inc. (U.S.)
    Delphi Genetics (Belgium)
    Scarab Genomics, LLC (U.S.)
    Yeastern Biotech Co., Ltd. (Taiwan)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Chemically Competent Cells
    Electrocompetent Cells
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Pharmaceutical and Biotechnology Companies
    Academic Research Institutes
    Contract Research Organizations (CROs)

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Competent Cells Market  Report 2019
1 Competent Cells Overview
    1.1 Product Overview and Scope of Competent Cells
    1.2 Classification of Competent Cells by Product Category
        1.2.1 United States Competent Cells Market Size (Sales Volume) Comparison by Type ( 2014-2024)
        1.2.2 United States Competent Cells Market Size (Sales Volume) Market Share by Type (Product Category)  in 2018
        1.2.3 Chemically Competent Cells
        1.2.4 Electrocompetent Cells
    1.3 United States Competent Cells Market by Application/End Users
        1.3.1 United States Competent Cells Market Size (Consumption) and Market Share Comparison by Application ( 2014-2024)
        1.3.2 Pharmaceutical and Biotechnology Companies
        1.3.3 Academic Research Institutes
        1.3.4 Contract Research Organizations (CROs)
    1.4 United States Competent Cells Market by Region
        1.4.1 United States Competent Cells Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 The West Competent Cells Status and Prospect ( 2014-2024)
        1.4.3 Southwest Competent Cells Status and Prospect ( 2014-2024)
        1.4.4 The Middle Atlantic Competent Cells Status and Prospect ( 2014-2024)
        1.4.5 New England Competent Cells Status and Prospect ( 2014-2024)
        1.4.6 The South Competent Cells Status and Prospect ( 2014-2024)
        1.4.7 The Midwest Competent Cells Status and Prospect ( 2014-2024)
    1.5 United States Market Size (Value and Volume) of Competent Cells ( 2014-2024)
        1.5.1 United States Competent Cells Sales and Growth Rate ( 2014-2024)
        1.5.2 United States Competent Cells Revenue and Growth Rate ( 2014-2024)

2 United States Competent Cells Market Competition by Players/Suppliers
    2.1 United States Competent Cells Sales and Market Share of Key Players/Suppliers ( 2014-2019)
    2.2 United States Competent Cells Revenue and Share by Players/Suppliers ( 2014-2019)
    2.3 United States Competent Cells Average Price by Players/Suppliers ( 2014-2019)
    2.4 United States Competent Cells Market Competitive Situation and Trends
        2.4.1 United States Competent Cells Market Concentration Rate
        2.4.2 United States Competent Cells Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Competent Cells Manufacturing Base Distribution, Sales Area, Product Type

3 United States Competent Cells Sales (Volume) and Revenue (Value) by Region ( 2014-2019)
    3.1 United States Competent Cells Sales and Market Share by Region ( 2014-2019)
    3.2 United States Competent Cells Revenue and Market Share by Region ( 2014-2019)
    3.3 United States Competent Cells Price by Region ( 2014-2019)

4 United States Competent Cells Sales (Volume) and Revenue (Value) by Type (Product Category) ( 2014-2019)
    4.1 United States Competent Cells Sales and Market Share by Type (Product Category) ( 2014-2019)
    4.2 United States Competent Cells Revenue and Market Share by Type ( 2014-2019)
    4.3 United States Competent Cells Price by Type ( 2014-2019)
    4.4 United States Competent Cells Sales Growth Rate by Type ( 2014-2019)

5 United States Competent Cells Sales (Volume) by Application ( 2014-2019)
    5.1 United States Competent Cells Sales and Market Share by Application ( 2014-2019)
    5.2 United States Competent Cells Sales Growth Rate by Application ( 2014-2019)
    5.3 Market Drivers and Opportunities

6  United States Competent Cells Players/Suppliers Profiles and Sales Data
    6.1 Merck KGaA (Germany)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Competent Cells Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Merck KGaA (Germany) Competent Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Promega Corporation (U.S.)
        6.2.2 Competent Cells Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Promega Corporation (U.S.) Competent Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Thermo Fisher Scientific, Inc. (U.S)
        6.3.2 Competent Cells Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Thermo Fisher Scientific, Inc. (U.S) Competent Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 New England Biolabs (U.S.)
        6.4.2 Competent Cells Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 New England Biolabs (U.S.) Competent Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Takara Bio (Japan)
        6.5.2 Competent Cells Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Takara Bio (Japan) Competent Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Agilent Technologies (U.S.)
        6.6.2 Competent Cells Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Agilent Technologies (U.S.) Competent Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Lucigen (U.S.)
        6.7.2 Competent Cells Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Lucigen (U.S.) Competent Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 QIAGEN N.V. (Germany)
        6.8.2 Competent Cells Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 QIAGEN N.V. (Germany) Competent Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 OriGene Technologies (U.S.)
        6.9.2 Competent Cells Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 OriGene Technologies (U.S.) Competent Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 Bioline (U.K.)
        6.10.2 Competent Cells Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Bioline (U.K.) Competent Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview
    6.11 Zymo Research (U.S.)
    6.12 Beijing TransGen Biotech Co., Ltd. (China)
    6.13 Source BioScience (U.K.)
    6.14 IBA GmBH (Germany)
    6.15 Genewiz (U.S.)
    6.16 BioDynamics Laboratory, Inc. (Japan)
    6.17 GCC Biotech (India)
    6.18 SMOBIO Technology (Taiwan)
    6.19 GeneScript Corporation (U.S.)
    6.20 Bio-Rad Laboratories (U.S.)
    6.21 Life Technologies (India) Pvt. Ltd.
    6.22 Cell Applications, Inc. (U.S.)
    6.23 Delphi Genetics (Belgium)
    6.24 Scarab Genomics, LLC (U.S.)
    6.25 Yeastern Biotech Co., Ltd. (Taiwan)

7 Competent Cells Manufacturing Cost Analysis
    7.1 Competent Cells Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Competent Cells

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Competent Cells Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Competent Cells Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Competent Cells Market Size (Value and Volume) Forecast ( 2019-2025)
    11.1 United States Competent Cells Sales Volume, Revenue Forecast ( 2019-2025)
    11.2 United States Competent Cells Sales Volume Forecast by Type ( 2019-2025)
    11.3 United States Competent Cells Sales Volume Forecast by Application ( 2019-2025)
    11.4 United States Competent Cells Sales Volume Forecast by Region ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer